Insmed Incorporated owns or licenses the following patents and patent applications in the United States and counterparts in certain foreign jurisdictions for the following products.
Amikacin Liposome Inhalation Suspension
(ALIS or Arikayce®)
| Patent No. or Publication No. | Patent Expiration |
|---|---|
| U.S. Patent No. 7,718,189 | 06/06/2025 |
| U.S. Patent No. 8,226,975 | 08/15/2028 |
| U.S. Patent No. 8,632,804 | 12/05/2026 |
| U.S. Patent No. 8,642,075 | 12/05/2026 |
| U.S. Patent No. 8,679,532 | 12/05/2026 |
| U.S. Patent No. 9,566,234 | 01/18/2034 |
| U.S. Patent No. 9,827,317 | 04/08/2024 |
| U.S. Patent No. 9,895,385 | 05/15/2035 |
| U.S. Patent No. 10,251,900 | 05/15/2035 |
| U.S. Patent No. 10,751,355 | 05/15/2035 |
| U.S. Patent No. 11,446,318 | 05/15/2035 |
| U.S. Patent No. 12,016,873 | 05/15/2035 |
| PCT Publication No. WO 2022/047292 | 08/30/2041 |
Your Privacy Choices
